Updated September 29 at 3:29pm
Life Sciences
96 results total, viewing 1 - 10
EpiVax Inc. has received a $600,000 grant from the National Institutes of Health through the Small Business Innovation Research program to improve a vaccine for the H7N9 avian influenza virus. more
A Providence-based national advocacy organization for mental illness research, Cure Alliance for Mental Illness, with support from the Brown Institute for Brain Sciences and the Norman Prince Neurosciences Institute, will host Rhode Island’s first-ever Brain Week, March 12-19. more
With economic development and job creation closely tied to land development, Rhode Island saw a number of real estate development projects abandoned midstream as a result of the Great Recession. Now, as our real estate economy is starting to … more
MindImmune Therapeutics Inc. will receive $500,000 in seed funding from Slater Technology Fund to support the drug discovery venture’s launch. more
Six Rhode Island companies have received state matching grants to leverage federal funds intended to promote innovation in technology. more
Four years ago, MedMates was conceived at a brainstorming session about making economic growth happen in Rhode Island. David Goldsmith, co-founder of the group focused on providing a voice and opportunities for businesses in the state's … more
Kelly Nevins is the first full-time executive director of MedMates, Rhode Island’s health care technology network group. She spoke recently with PBN about its short- and long-term goals and her role with the organization. more
Diane Hoffman-Kim is associate professor of medical science and engineering in the Department of Molecular Pharmacology, Physiology, and Biotechnology, and the Center for Biomedical Engineering at Brown University. She was lead author on a recent study showing how miniature brains can be developed in the laboratory for research purposes at surprisingly low cost. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
Dr. Anne S. De Groot is the founder, immune engineer, chief scientific officer and CEO of Providence-based vaccine company EpiVax, which champions the "vaccines-on-demand" movement. She talks with Providence Business News about her experience as a panelist at a health care conference, "The Immunology Revolution: Here Now or Hurry Up and Wait?" more
1 | 2 | 3 | 4 | 5 | 6 | 7 10 | Next »